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Th17 cells elicited by pathogens and
tissue-resident homeostatic Th17 cells
elicited by commensals are unclear.
Omenetti et al. show that tissue-resident
Th17 cells, in contrast to pathogen-
elicited Th17 cells, exhibit little plasticity
towards inflammatory cytokines, show
muted metabolism, and do not
participate in inflammatory reactions.
These findings highlight the link between
metabolic fitness and functional state.
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T helper 17 (Th17) cells are pathogenic inmany inflam-
matory diseases, but also support the integrity of the
intestinal barrier in a non-inflammatory manner. It is
unclear what distinguishes inflammatory Th17 cells
elicited by pathogens and tissue-resident homeostat-
ic Th17 cells elicited by commensals. Here, we
compared the characteristics of Th17 cells differenti-
ating in response to commensal bacteria (SFB)
to those differentiating in response to a pathogen
(Citrobacter rodentium). Homeostatic Th17 cells
exhibited little plasticity towards expression of inflam-
matory cytokines, were characterized by a meta-
bolism typical of quiescent or memory T cells, and
did not participate in inflammatory processes. In
contrast, infection-induced Th17 cells showed exten-
sive plasticity towards pro-inflammatory cytokines,
disseminated widely into the periphery, and engaged
aerobic glycolysis in addition to oxidative phosphory-
lation typical for inflammatory effector cells. These
findings will help ensure that future therapies directed
against inflammatory Th17 cells do not inadvertently
damage the resident gut population.
INTRODUCTION
T helper 17 (Th17) cells are intensely studied because of their
known role in the pathogenicity of a variety of inflammatory disor-
ders (Wang et al., 2011; Weaver et al., 2013). However, less well
understood are the characteristics of tissue-resident homeostatic
intestinalTh17cells thatdifferentiate in response to themicrobiota,
notably segmented filamentousbacteria (SFB), and fulfil important
roles in protection of the gut barrier (Chung et al., 2012; Le´cuyer
et al., 2014). To complicate matters further, intestinal Th17 cell
responses are also linked with the pathology of inflammatory
bowel disease (IBD) (Jostins et al., 2012), and it has been sug-
gested that intestinal Th17 cells contribute to inflammatory dis-
ease elsewhere in the body (Lee et al., 2011; Wu et al., 2010).Immunity 51, 1–1
This is an open access article undSubstantial efforts have been made to define gene regulatory
networks that discriminate pathogenic and non-pathogenic
Th17 cells (Gaublomme et al., 2015; Lee et al., 2012). A caveat
is that this distinction is so far largely on the basis of Th17 cells
generated in vitro in the presence of different cytokine cocktails
compared with Th17 cells isolated from the inflamed central ner-
vous system (CNS) of mice with active experimental autoimmune
encephalomyelitis (EAE). Because Th17 cells are influenced by
the local tissue environment they find themselves in and are
affected by a multitude of environmental factors, including diet
(Endo et al., 2015; Kleinewietfeld et al., 2013; Wu et al., 2013),
aryl hydrocarbon receptor (AHR) ligands (Zelante et al., 2013),
circadian rhythm (Yu et al., 2013), and the microbiota, it is unlikely
that in-vitro-differentiated Th17 cells recapitulate the spectrum of
biology present in ex vivo Th17 cells. Here, we have therefore
focused on intestinal Th17 cells either present during homeostasis
or induced by infection. This was done by comparing the charac-
teristics of SFB-induced Th17 cells and those of Th17 cells differ-
entiating in response to a pathogen (Citrobacter rodentium). Th17
cells induced in response to C. rodentium are necessary for
clearing the infection, and this results in transient but reversible tis-
sue damage due to their inflammatory properties.
At present, it is unclear what distinguishes inflammatory Th17
cells elicited by pathogens (e.g., C. rodentium) and homeostatic
tissue-resident Th17 cells elicited by commensals (e.g., SFB). A
further consideration is the success in therapeutic targeting of in-
flammatory Th17 cells in conditions such a psoriasis, or multiple
sclerosis via antibodies against interleukin-17A (IL-17A) or
IL-12p40 (Patel and Kuchroo, 2015). Such antibodies, on the
other hand, proved to worsen the symptoms of Crohn’s patients
(Hueber et al., 2012). Although reduction of inflammatory cyto-
kine production by Th17 cells does not directly affect the cells
themselves, other strategies such as inhibition of retinoic acid-
related orphan receptors gt (RORgt) might compromise the
maintenance of the homeostatic intestinal Th17 cell population.
Transient inhibition of RORgt in a mouse model has been shown
to reduce Th17 cell differentiation in response to infection with
C. rodentium, while sparing group 3 innate lymphoid cells
(ILC3s), however the effect on resident small intestinal Th17 cells
was not tested (Withers et al., 2016). It is therefore important to
understand the intrinsic differences between inflammatory and
tissue-resident Th17 cells to ascertain that future therapies3, July 16, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Colonization with SFB and Infection with C. rodentium
Induce Different Th17 Responses
(A) Relative abundance of SFB in the feces of mice reconstituted with SFB+
feces on 0 (n = 10), 1 (n = 10), 2 (n = 12), and 4 (n = 6) weeks after gavage. SFB
genomic 16s was quantified in the feces by qPCR analysis. Abundance of SFB
was normalized to Eubacteria.
(B and D) Absolute numbers of Th17 cells in the small intestine ofmice colonized
with SFB (B) and colon of mice infected with C. rodentium (D) at 0 (n = 6 and 5),
1 (n = 10 and 6), 2 (n = 11 and 6), and 4 (n = 10 and 9) weeks after gavage.
(C)C. rodentiumburden in the colon of infectedmiceat 0 (n=5), 1 (n = 6), 2 (n=6),
and 4 (n = 9) weeks after gavage.
In the graphs, bars show the mean ± SEM (A, B, and D) or median (C) and
each symbol represents an individual mouse from two pooled independent
experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way
ANOVA with Dunnett’s post-test. n.d., not detected. See also Figure S1.
Please cite this article in press as: Omenetti et al., The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17
Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004directed against inflammatory Th17 cells do not inadvertently
damage the resident gut population.
Our data show that tissue-resident homeostatic Th17 cells
induced by SFB do not participate in inflammatory reactions
and exhibit a transcriptional profile indicating downmodulation
of inflammatory capacity. In contrast, Th17 cells elicited in
response to C. rodentium exhibit a high degree of plasticity
towards an inflammatory cytokine profile and a transcriptome
reflecting inflammatory effector potential. Furthermore, the
metabolism of tissue-resident homeostatic Th17 cells resembles
more that of resting memory cells, whereas C.-rodentium-
elicited Th17 cells primarily engage aerobic glycolysis that is
commonly associated with inflammatory effector cells. Our find-
ings indicate that there are two functionally distinct Th17 cell
populations that might reside in the gut simultaneously.
RESULTS
Segmented Filamentous Bacteria and Citrobacter
rodentium Induce Qualitatively Different Th17
Responses
SFB are one of the most potent and well-characterized
commensal inducers of Th17 cells. Indeed, monocolonization2 Immunity 51, 1–13, July 16, 2019of germ-free mice with SFB promotes a robust Th17 cell
response in the small intestinal lamina propria and to a minor
extent in the large intestine lamina propria (Ivanov et al., 2009).
To further explore Th17 cell induction by SFB, we colonized
SFB-negative specific-pathogen free (SPF) mice with SFB by
oral gavage with feces from SFB monocolonized germ-free
mice. Subsequently, SFB-containing feces were collected from
the SFB+ mice housed in our SPF colony and used to introduce
SFB into experimental mice. To trace the kinetics of Th17 differ-
entiation upon SFB colonization, we introduced SFB into IL-17A
fate reporter mice (Il17aCreR26ReYFP) by oral gavage, and Th17
cells, permanently marked as eYFP+ cells, as well as SFB colo-
nization were then monitored 1, 2, and 4 weeks later. SFB abun-
dance peaked in the feces of colonized mice one week after
introduction and then diminished over time (Figure 1A). Although
SFB abundance was lower at week 4, it remained detectable at
any later time-point, in accordance with other reports showing
that SFB is contained after introduction into wild-type animals,
but never completely cleared (Kumar et al., 2016). The expansion
and containment of SFB correlated with the induction and
contraction of Th17 cell numbers in the small intestinal lamina
propria (Figure 1B), confirming that Th17 cells are induced
upon SFB expansion and, in turn, contribute to control SFB
load. Although SFB is confined to the small intestine (SI), Th17
cells were also found in the colon after colonization with SFB,
albeit at lower numbers (Figure S1A).
Although SFB colonization results in generation of Th17 cells in
the small intestine, infections with intestinal pathogens such as
Citrobacter rodentium that target the colon also induce Th17
responses (Mangan et al., 2006). To understand whether
homeostatic SFB-elicited Th17 cells and pro-inflammatory
C.-rodentium-elicited Th17 cells are induced with similar
kinetics, we infected SFB-free Il17aCreR26ReYFP mice with
C. rodentium and followed Th17 cell induction in the colon on
weeks 1, 2, and 4. Similarly to what was observed for SFB, the
bacterial load of C. rodentium reached its peak in the first
week and then progressively declined until it was cleared by
week 4 (Figure 1C). Th17 cells induced by C. rodentium peaked
at week 2, similarly to those induced by SFB, however C.-roden-
tium-elicited Th17 cells had not contracted by week 4 despite
complete bacterial clearance (Figure 1D).
Th17 cells elicited by C. rodentium are known to produce
large amounts of interferon-g (IFN-g) (Ahlfors et al., 2014). In
contrast, Th17 cells generated upon SFB colonization produce
mostly IL-17A (Ivanov et al., 2009), although a different study re-
ported a modest increase in IFN-g upon SFB colonization
(Gaboriau-Routhiau et al., 2009). Due to differences in animal
models, chosen time points and intestinal microbiota composi-
tion in these studies, it is difficult to draw conclusions regarding
the cytokine profiles of Th17 cells elicited in these two condi-
tions. For this reason, we compared cytokine production after
ex vivo stimulation with phorbol myristate acetate (PMA) and
ionomycin of eYFP+ Th17 cells from Il17aCreR26ReYFP mice,
colonized with either SFB or C. rodentium. Th17 cells generated
in the first week mostly expressed IL-22 with IL-17A, or just
IL-17A in either condition (Figures 2A and 2B) and started ex-
pressing IFN-g, especially in C.-rodentium-infected mice, in
the later phase of the infection (at 2 and 4 weeks), consistent
with published reports on SFB- and C.-rodentium-elicited
Figure 2. SFB- and C.-rodentium-Elicited Th17 Cells Have Different Cytokine Profiles
(A–D) Representative intracellular staining for IL-17A and IL-22 (A) or IFN-g (C) and corresponding quantifications in (B) and (D) in Th17 cells from the SI of mice
colonized with SFB and colon of mice infected with C. rodentium at 1 (n = 9 and 6), 2 (n = 11 and 6), and 4 (n = 14 and 9) weeks after gavage. Lamina propria cells
were isolated at the indicated time point, re-stimulatedwith PMA and ionomycin and Brefeldin A for 2 h, and analyzed by FACS. Bars show themean ± SEM for the
indicated populations, and each symbol represents an individual mouse from two pooled independent experiments.
(E) Cytokine concentration in supernatants of FACS-purified Th17 cells from the SI of mice colonized with SFB or colon of mice infected with C. rodentium. In the
graphs, bars show themean ± SEM, and each symbol represents a technical replicate. Cells were FACS-purified from one sample per group, obtained by pooling
3–6 mice. Results are representative of three independent experiments.
(F) Fold-change (FC) induction of listed genes quantified by qPCR in the SI (green) and colon (orange) of mice colonized with SFB or infected with C. rodentium,
1 week after gavage. Fold change is calculated on the matching organs from untreated mice and gene expression is normalized against b-2-microglobulin. Data
are from two pooled independent experiments. *p < 0.05, **p < 0.01, ****p < 0.0001 by two-way ANOVA with Sidak’s post-test. Please see also Figure S2.
Please cite this article in press as: Omenetti et al., The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17
Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004T cells (Atarashi et al., 2015). Although a transient induction of
IFN-g+IL-17A+ Th17 cells was observed in SFB colonized
mice at 2 weeks after infection, the proportion of IFN-
g+IL-17A Th17 cells was significantly higher in C. rodentium
colonized mice than in SFB colonized mice at all time points.
(Figures 2C and 2D). SFB-elicited Th17 cells resident in the co-
lon displayed a similar profile throughout the chosen time points
compared with time points of homeostatic small intestinal Th17
cells (Figure S2A). In contrast C.-rodentium-elicited Th17 cells
found in the small intestine diverged from their counterpart in
the colon after the first week and showed a muted cytokine
expression (Figure S2B). Although re-stimulation with PMA
and ionomycin is a useful tool to identify subpopulations of
Th17 cells based on their cytokine production, it does
not necessarily reflect the actual production of the protein
in vivo. For this reason, we FACS-sorted intestinal Th17cells from Il17aCreR26ReYFP mice colonized with SFB or
C. rodentium 2 weeks after infection and cultured them without
further stimulation to assess their production of cytokines on the
protein level. Interestingly, IL-22 was secreted to a similar extent
by SFB- and C.-rodentium-elicited Th17 cells, whereas IL17-A
secretion was higher in SFB-induced Th17 cells, and increased
amounts of IFN-g were secreted only by C.-rodentium-elicited
Th17 cells (Figure 2E).
In order to investigate what factors might mediate the
differences in functionality between SFB- and C.-rodentium-
elicited Th17 cells, we next determined whether SFB versus
C. rodentium infection induces different molecules in intestinal
tissue samples comprising epithelial and hematopoietic cells
(Figures 2F and S2C).
As previously reported, SFB infection led to upregulation of
serum amyloid A1 (Saa1) in the small intestinal tissue, which isImmunity 51, 1–13, July 16, 2019 3
Figure 3. Peripheral Th17 Cells Retain Their Antigen-Specificity in
Response to SFB and C. rodentium
Shown in (A) are the absolute numbers of Th17 cells in the spleen of mice
colonized with SFB or infected with C. rodentium at 0 (n = 11 and 5), 1 (n = 10
and 6), 2 (n = 12 and 6), and 4 (n = 6 and 8) weeks after gavage. Symbols show
the mean ± SEM. Cytokine concentration in supernatants of FACS-purified
Th17 cells from the spleen and SI of mice colonized with SFB (B) or from the
spleen and colon of mice infected withC. rodentium (C), cultured with DCs and
SFBpeptide (B) or EspA (C). Bars show themean + SEM of technical replicates
(n = 3–4). Cells were FACS-purified from one sample per group, obtained by
pooling 3–6 mice. Results are representative of three (B) and two (C) inde-
pendent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by two-
way (A) or one-way (B and C) ANOVA with Sidak’s (A) or Tukey’s (B and C)
post-test. n.d., not detected. See also Figure S3.
Please cite this article in press as: Omenetti et al., The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17
Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004linked with the induction of Th17 cells (Sano et al., 2015). This
was also observed, to a lesser extent, in the colon of
SFB-colonized mice, but not in tissue samples from
C.-rodentium-infected mice. Also characteristic for SFB was
the induction of fructosyltransferase 2 (Fut2) which was shown
to foster bacterial species that metabolize fucosylated sub-
strates and protect against infection with Salmonella typhimu-
rium (Schnupf et al., 2017). Dual oxidase maturation factor 2
(Duoxa2), the maturation factor for reactive oxygen species
(ROS)-generating enzyme dual oxidase 2 (Duox2) was upregu-
lated both in tissue from SFB- as well as C.-rodentium-
infected mice. This is consistent with the role of ROS in the
induction of SFB- as well as C.-rodentium-elicited intestinal
Th17 cells (Atarashi et al., 2015). Il23a, Il1b, Cxcl1, and4 Immunity 51, 1–13, July 16, 2019Cxcl2 on the other hand were barely induced in intestinal
tissue samples by SFB colonization, whereas they were
highly expressed in colonic but not small intestinal tissue
from C.-rodentium-infected mice.
Thus, infection with a commensal bacterium compared with
a pathogen has distinct consequences for the response of
epithelial and hematopoietic cells in mucosal tissue.
Cytokine Responses of Th17 Cells in the Periphery
Recapitulate Their Intestinal Counterparts
We next investigated the dissemination of Th17 cells elicited by
SFB or C. rodentium into the periphery over a time point of
4 weeks after colonization. SFB-elicited Th17 cells were
detectable in the spleen, albeit at very low numbers. In contrast,
C.-rodentium-elicited Th17 cells seeded the periphery in sub-
stantial numbers with a peak 2 weeks after infection, but still
showed high numbers 4 weeks later (Figure 3A). FACS-sorted
Th17 cells from the spleen and intestine were then cultured
with dendritic cells (DCs) and immunodominant epitopes for
either SFB orC. rodentium (EspA) to determine cytokine produc-
tion in response to recall. SFB-induced Th17 cells isolated from
the small intestine produced some IL-22 and IL-17A, but not
IFN-g even without re-stimulation, whereas those isolated from
the spleen did not produce cytokines unless re-stimulated, but
then recapitulated the specificity and cytokine profile of small in-
testinal Th17 cells (Figure 3B). C.-rodentium-induced Th17 cells
isolated from the colon as well as the spleen produced concen-
trations of IL-22 and IL-17A protein upon re-stimulation, but in
contrast to SFB-specific Th17 cells, they produced particularly
high amounts of IFN-g (Figure 3C). Thus, SFB-specific Th17 cells
have very limited expansion potential and are found in very small
numbers only in the periphery where re-stimulation by SFB pep-
tide illustrates their origin and specificity as well as their im-
printed cytokine profile. C.-rodentium-induced Th17 cells on
the other hand distribute to the periphery in large numbers and
exhibit an inflammatory cytokine profile indicative of plasticity
towards a Th1-like cytokine pattern with high protein concentra-
tions of IFN-g.
Homeostatic Tissue-Resident Th17 Cells Do Not Clear
C. rodentium Infection
Small intestinal Th17 cells that arise in response to commensal
microbes such as SFB might be expected to display a
‘‘non-inflammatory’’ cytokine profile. However, SFB and intesti-
nal Th17 cells have been implicated in inflammatory disorders
outside the intestine, including EAE (Lee et al., 2011; Wu et al.,
2010). To understand whether the presence of intestinal
Th17 cells influences the course of EAE in our model of SFB
re-introduction, we immunized SFB+ and SFB mice with oligo-
dendrocyte glycoprotein peptide in complete Freund’s adjuvant
(MOG-CFA) to induce EAE. Although clear differences in SFB
abundance (Figure S3A) and numbers of intestinal Th17 cells
(Figure S3B) were observed between the two groups, there
was no difference in disease onset and severity after immuniza-
tion with MOG-CFA (Figure S3C). Furthermore, frequency of
Th17 cells in the spinal cord (Figure S3D) did not vary between
SFB+ and SFB mice. This suggests that induction of inflamma-
tory Th17 cell responses in the periphery are not influenced by
resident intestinal Th17 cells and the presence of SFB.
Figure 4. Homeostatic Tissue-Resident Intestinal Th17 Cells Do Not Clear C. rodentium Infection
(A) Schematic drawing of the experimental protocol. Mice were orally gavagedwith SFB+ feces 4 weeks before the infection withC. rodentium (at day 0). Six days
before the infection with C. rodentium (day 6), mice were intra-peritoneally injected with FTY720 (3 mg/kg) or control vehicle every day. FTY720 and control
vehicle administration continued after the infection every other day until the end of the experiment.
(B) Survival curve of C.-rodentium-infected mice treated with vehicle or FTY720.
(C) C. rodentium burdens in colon and liver.
(D–J) Absolute numbers of colonic Th17 cells. Representative intracellular staining for IL-17A and IFN-g (E) or IL-22 (H) and quantification (F and I) in colonic Th17
cells. IFN-g (G) and IL-22 (J) protein content in colon explant cultures. Bars show median (C) or mean ± SEM (D, F, G, I, and J) and each symbol represents an
individual mouse (n = 8). Results are representative of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 by Mantel-Cox (B), Mann-Whitney (C) or
Student’s t test (D, F, G, I, and J). See also Figure S4.
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Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004However, Th17 cells are clearly involved in inflammatory pro-
cesses within the intestinal environment, such as IBD, but it re-
mains to be determined whether pro-inflammatory Th17 cells
contributing to intestinal inflammation are Th17 cells de novo
generated under pro-inflammatory conditions or rather tissue-
resident ‘‘homeostatic’’ Th17 cells elicited by SFB that acquire
a pro-inflammatory phenotype. To address this question,
we colonized mice with SFB to induce differentiation of tissue-resident homeostatic Th17 cells in the intestine and then infected
them with C. rodentium. Intestinal Th17 cell differentiation is
initiated in the mesenteric lymph node (mLN) and the cells
subsequently migrate to the intestinal lamina propria
(Schreiber et al., 2013). To block the migration of newly gener-
atedC.-rodentium-specific Th17 cells from the mLN to the intes-
tine, we administered the drug FTY720 after SFB colonization
(Murphy et al., 2012), as illustrated in Figure 4A. FTY720 is anImmunity 51, 1–13, July 16, 2019 5
Please cite this article in press as: Omenetti et al., The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17
Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004analogue of sphingosine-1-phosphate, and its administration
prevents lymphocyte egress from the lymph nodes and traf-
ficking to target tissues (Chiba et al., 2006).
FTY720 treatment did not affect the numbers or cytokine pro-
file of SFB-elicited Th17 cells in the colon, and they remained at a
baseline number of 3.7 3 103 cells (Figure S4A–S4C).
Upon infection withC. rodentium, SFB-colonized mice treated
with FTY720 succumbed to the infection between day 9 and 14
(Figure 4B) and displayed higher bacterial loads in the colon and
dissemination to the liver compared than mice receiving only the
vehicle (Figure 4C). Vehicle-treated mice infected with
C. rodentium showed an increase in the Th17 population to
8.7 3 104 cells. Administration of FTY720 resulted in a marked
decrease in numbers of colonic Th17 cells (Figure 4D), back to
baseline numbers seen after Th17 cell induction by SFB (Fig-
ure S1A). This suggested that SFB-elicited Th17 cells resident
in the colon did not expand in response to C. rodentium. More-
over, a smaller number of colonic Th17 cells from FTY720-
treated mice were IFN-g+IL-17A+ and IFN-g+IL-17A compared
with Th17 cells from mice treated with the vehicle (Figures 4E
and 4F).
Consistently, production of IFN-g was markedly decreased in
the colons ofmice receiving the drug (Figure 4G). Thus, Th17 cells
elicited by SFB and resident in the colon of FTY720-treated mice
did not acquire the ‘‘classical’’ Th17 pro-inflammatory phenotype
observed in Th17 cells elicited byC. rodentium infection, whereas
the latter could not contribute IFN-g because their migration to the
colon was blocked by FTY720. Furthermore, the proportion of
IL-22-producing cells and protein concentration of IL-22 were
substantially reduced (Figure 4H–4J) in line with the finding that
themajor source of IL-22 beyondday 5 after infection are adaptive
T cells with a Th17 cell origin (Ahlfors et al., 2014; Basu et al.,
2012). However, the number of ILC3s, which supply IL-22 prior
to the induction of the adaptive response, was not affected by
FTY720 treatment in C.-rodentium-infected mice (Figure S4D).
As C.-rodentium-specific Th17 cells were blocked from entry
into the intestine, the infection could not be contained, and the
mice succumbed to bacterial dissemination.
Homeostatic Tissue-Resident and Inflammatory
Intestinal Th17 Cells Are Characterized by Distinct
Metabolism
To characterize the molecular state associated with the different
functional activities of Th17 cells induced by commensal SFB
versus the pathogenC. rodentium, we profiled the transcriptome
of these two populations by using RNA-sequencing (RNA-seq).
We colonized mice with either SFB or C. rodentium and
harvested Th17 cells from both small intestine and colon after
2 weeks at the peak of Th17 cell expansion. Hierarchical
clustering revealed that the greatest variations in gene expres-
sion occurred between Th17 cells isolated from the colon of
C.-rodentium-infected mice and the remaining three groups,
including Th17 cells from the small intestine and colon of SFB-
colonized mice and from the small intestine of C.-rodentium-in-
fected mice (Figure 5A). C.-rodentium-elicited Th17 cells from
the SI displayed higher similarity to homeostatic Th17 from the
SI and colon of mice colonized with SFB than to inflammatory
Th17 cells from the colon of mice colonized with C. rodentium.
(Figure 5A). In correspondence with what was previously6 Immunity 51, 1–13, July 16, 2019observed at the protein level (Figure 2E), small intestinal SFB-eli-
cited Th17 cells expressed higher read counts for Il17a and com-
parable read counts for Il22 compared with pro-inflammatory
C.-rodentium-derived colonic Th17 cells. Furthermore, reads
for T-box-containing protein expressed in T cells (Tbx21) and
Ifng, which are expressed by Th17 cells that switch towards a
pro-inflammatory profile, were increased in C.-rodentium- but
not SFB-induced colonic Th17 cells (Figure 5B).
The natural habitat for SFB is the small intestine, whereas
C. rodentium colonizes the colon. Considering the high degree
of similarity between SFB-elicited Th17 cells from the colon
and the small intestine, we asked whether the comparison be-
tween these two homeostatic populations and inflammatory
C.-rodentium-derived colonic Th17 cells would result in similar
sets of differentially expressed genes. As shown in Figure 5C,
the vast majority of differentially expressed genes appeared
in both comparisons: SFB-derived colonic Th17 cells versus
C.-rodentium-derived colonic Th17 cells and SFB-derived small
intestinal Th17 cells versus C.-rodentium-derived colonic Th17
cells. Moreover, this similarity trend persisted also in the non-
differentially expressed genes with only a handful of genes ex-
hibiting opposite trends in the two comparisons. For this reason,
we decided to use SFB-elicited colonic Th17 cells as our
homeostatic control population and compared it to inflammatory
C.-rodentium-elicited colonic Th17 cells.
A consistent observation for SFB-elicited Th17 cells was the
inhibition of pro-inflammatory pathways, including Janus kinase
(JAK) and signal transducers and activators of transcription
(STAT) signaling, nitric oxide, and ROS production compared
with that in C.-rodentium-derived Th17 cells (Figure 5D). In
contrast, anti-inflammatory pathways, such as sumoylation,
phosphatase and tensin homolog (PTEN), and sirtuin signaling
were activated in SFB-derived Th17 cells. Expression of Sirt1,
which belongs to the sirtuin family of NAD+-dependent deacety-
lases, is downregulated in IBD biopsies and increased in
mucosal samples of IBD patients successfully treated with Inflix-
imab (Caruso et al., 2014).
Transcriptional regulators and chromatin modifiers involved in
regulating cell growth, differentiation, and apoptosis such as
Rhob, Znf217, Rnd3, Xiap, EP300, and Sp1 were upregulated
in SFB-induced Th17 cells (Figure S5A) as were signaling modi-
fiers, cell cycle inhibitors, and anti-apoptotic factors connected
to the PTEN pathway (Figure S5B). A further indication of the
less inflammatory nature of SFB-elicited Th17 cells is the
enrichment for mitochondria-encoded genes involved in oxida-
tive phosphorylation (OXPHOS) (mt-Nd1, mt-Nd2, mt-Nd3,
mt-Nd4,mt-Nd4l, andmt-Nd6) comparedwithmarkers of gluco-
neogenesis and glycolysis such asCrtc2 and Ldha, respectively,
that are downregulated in SFB-elicited Th17 cells but highly ex-
pressed on inflammatory C.-rodentium-elicited Th17 cells
(Figure S5C).
In order to investigate whether our RNA-seq data from ex vivo
intestinal Th17 cells show any overlap with in vitro generated
‘‘pathogenic’’ versus ‘‘non-pathogenic’’ Th17 cells, we compared
our dataset from colonic SFB- versus C.-rodentium-elicited
Th17 cells to published gene expression data from Th17 cells
differentiated in the presence of transforming growth factor-b
(non-pathogenic Th17) or IL-23 (pathogenic Th17) (Ghoreschi
et al., 2010). Out of 197 genes differentially expressed between
Figure 5. Intestinal Th17 Cells Elicited by
SFB and C. rodentium Have Distinct Tran-
scriptional Profiles
(A) RNA-sequencing analysis of Th17 cells from
the SI and colon of C. rodentium (Citro)-infected
and SFB-colonized mice, presented as heatmap
of condition similarity showing Poisson distance
between experimental groups.
(B) Gene expression in Th17 cells from the SI
and colon of C.-rodentium-infected and SFB-
colonized mice, presented as normalized read
counts (TPM).
(C) Scatter plot of differentially expressed genes
(log2-fold change) in SFB SI versus C. rodentium
colon against SFB colon versus C. rodentium
colon. Each dot represents a gene differentially
expressed (adjusted p < 0.05) in at least one
comparison. Specifically, genes in green are
significantly different in the SFB SI versus
C. rodentium colon comparison; genes in blue are
significantly different in SFB colon versus
C. rodentium colon comparison; and genes in red
are significantly different in both comparisons.
(D) Top 15 canonical pathways in colonic SFB-
versus C. rodentium-induced Th17 cells identified
by ingenuity pathway analysis (IPA) and ranked on
p value. The colors indicate activation Z-score of
each pathway with red corresponding to positive
Z-scores, blue to negative Z-scores, and white to
no activity pathway available. *p < 0.05, **p < 0.01
by one-way ANOVA with Tukey’s post-test. See
also Figure S5.
Please cite this article in press as: Omenetti et al., The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17
Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004pathogenic and non-pathogenic in-vitro-differentiated Th17 cells,
189 genes were detectable in colonic SFB- or C.-rodentium-
elicited Th17 cells. Among these 189 genes (depicted in Fig-
ure S5D), 33 genes were differentially expressed to a significant
extent in our dataset and followeda consistent trend in tissue-resi-
dent, SFB-elicited Th17 cells compared with in vitro ‘‘regulatory’’
Th17 cells aswell as inC.-rodentium-elicited Th17cells compared
with ‘‘pathogenic’’ Th17 cells (Figures S5D–S5F). Markers
previously observed in ‘‘non-pathogenic’’ versus ‘‘pathogenic’’
in-vitro-differentiated Th17 cells, such as Maf, Il10, or Tbx21
were differentially expressed in SFB versus C. rodentium Th17
cells, respectively (Figure S5D–S5F).
Further focus on the metabolism in the two Th17 cell types
illustrated that C.-rodentium-elicited Th17 cells were enriched
in metabolic pathways such as pyruvate metabolism, amino
acid biosynthesis, purine, and pyrimidine metabolisms (Fig-
ure 6A). The usage of these metabolic pathways is consistent
with the behavior of activated T cells, which display increased
capacity for glucose uptake, pyruvate generation, and demand
for nucleotides and other biomass to support their rapid prolifer-
ation and generation of effector molecules (Olenchock et al.,
2017). Effector T cells also increase mitochondrial OXPHOS
upon activation, together with anaerobic glycolysis, although
the latter remain the most substantially increased metabolismin these cells (van der Windt et al., 2012;
Wang et al., 2011). In accordance with
this observation, expression profile anal-
ysis indicated an upregulation of bothOXPHOS and glycolytic pathways in C.-rodentium-induced
Th17 cells, whereas tissue-resident homeostatic Th17 cells
seemed to rely mainly on OXPHOS (Figure 6A). To further inves-
tigate metabolic phenotypes of tissue-resident homeostatic and
C.-rodentium-elicited Th17 cells, we used reporter metabolite
analysis and identified those metabolites around which tran-
scriptional changes occur (see STAR Methods). This analysis
showed that tissue-resident homeostatic Th17 cells upregulated
reducing agents, including nicotinamide adenine dinucleotide
phosphate (NADPH) and glutathione (GSH) (Figure 6B and
Table S1), which are crucial to balance the oxidative stress
generated by OXPHOS. C.-rodentium-elicited Th17 cells, on
the other hand, upregulated energy metabolites in the cytosol
(Figure 6B and Table S1) and genes encoding glycolytic en-
zymes (Hk1, Pfkl, Aldoa, Eno1, Pkm, and Ldha) (Figure 6C).
Given that the RNA-seq data suggested pronounced meta-
bolic differences between the tissue-resident and infection-
induced Th17 cells, we carried out extracellular flux analysis
in order to define the bioenergetic profiles of these popula-
tions. The basal oxygen consumption rate (OCR), an indicator
of OXPHOS, was slightly higher in C.-rodentium- than in
SFB-derived intestinal Th17 cells (Figure 7A). Furthermore,
we observed a significant increase of extracellular acidification
rate (ECAR), an indicator of glycolysis, in C.-rodentium-elicitedImmunity 51, 1–13, July 16, 2019 7
Figure 6. SFB- and C.-rodentium-elicited intestinal Th17 cells
display different metabolic phenotypes
(A) Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways
enriched in SFB- and C.-rodentium-elicited colonic Th17 cells, on the basis of
upregulated genes with adjusted p < 0.001.
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coupled respiration than did SFB-derived Th17 cells (Fig-
ure 7C), in agreement with the reporter metabolite analysis in
Figure 6B. Collectively, these data support the findings from
our RNA-seq analysis and suggest that C.-rodentium-derived
Th17 cells exhibit an energetic glycolytic phenotype, whereas
SFB-derived Th17 cells show a resting aerobic profile, mainly
dependent on OXPHOS (Figure 7D).
Previous reports have linked changes in mitochondrial
morphology to different metabolic phenotypes (Rambold and
Pearce, 2018). Analysis of themitochondrial network by confocal
microscopy showed that SFB-elicited Th17 cells displayed an
elongated mitochondrial morphology (Figure 7E). In contrast, in
C.-rodentium-elicited Th17 cells, there was a significantly higher
fraction of individual (not linked to a network) and shorter
mitochondria than in SFB-elicited cells (Figures 7E–7G). None-
theless, we did not detect changes in mitochondrial content
(evaluated as total mitochondrial area per cell) (Figure 7H). These
results are in line with previous findings associating a tubular and
connected mitochondrial network with cells relying mainly in
OXPHOS and a more fragmented morphology with cellular pop-
ulations exhibiting higher glycolytic activity (Buck et al., 2016;
Mishra and Chan, 2016).
Altogether, these data confirmed that tissue-resident, SFB-eli-
cited Th17 cells, in contrast to C. rodentium-induced Th17 cells,
showed muted effector functions and a metabolism that sup-
ports the attenuated energy requirements of this homeostatic
population.
DISCUSSION
Th17 cells are considered important players in the orchestration
of inflammatory and autoimmune diseases. Multiple therapeutic
approaches targeting Th17 cells or their cytokine IL-17 have
shown promising results in ameliorating inflammation (Patel
and Kuchroo, 2015; Sherlock et al., 2012). However, what is
rarely taken into consideration is the fact that gut-indigenous
Th17 cells are important for barrier protection and might be vic-
tims of therapeutic approaches with potential deleterious long-
term effects. An example is the unsuccessful targeting of IL-17
in Crohn’s patients, which resulted in increased adverse effects
(Hueber et al., 2012). However, it is clear that Th17 cells are also
linked to intestinal inflammatory diseases such as IBD, where
they are highly enriched and linked to several genetic risk loci
(Kempski et al., 2017; Knights et al., 2013).
In this study, we have set out to define the differences in in-
testinal Th17 cells that are either tissue-resident and beneficial
for barrier maintenance or induced by infection, effective at
dealing with the threat but displaying a highly inflamma-
tory profile.
In mice, Th17 cells in the gut are largely induced by
commensal SFB (Ivanov et al., 2009), which play an important(B) Selection of differentially upregulated reporter metabolites involved in en-
ergy generation and redox reactions in SFB- andC.-rodentium-elicited colonic
Th17 cells (adjusted p < 0.05).
(C) Metabolism-related genes increased in C.-rodentium-induced colonic
Th17 cells (adjusted p < 0.05) (in red) as well as the associated reactions
involved in glycolysis. See also Table S1.
Figure 7. SFB- and C.-rodentium-Intestinal Th17 Cells Have Distinct Bioenergetic Profiles and Mitochondrial Morphology
Th17 cells from the SI of SFB-colonized mice and the colon of C.-rodentium-infected mice were FACS-sorted and used for further analysis.
(A) Oxygen consumption rate (OCR) at baseline and in response to oligomycin (Oligo), carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP), and
rotenone plus antimycin (R + A).
(B) Baseline extracellular acidification rate (ECAR) in relation to ECAR of SFB-elicited Th17 cells.
(C) Measurement of ATP-coupled respiration.
(D) OCR (measure of OXPHOS) plotted against ECAR (measure of glycolysis). Data are from 2–3 pooled independent experiments and are shown asmean ± SEM
***p < 0.001, ****p < 0.0001 by Student’s t test.
(E–H) Z-stack images were used to evaluate mitochondrial morphology by confocal microscopy. Mitochondria were stained withMitoTracker Red CMXRos (red),
nuclei with DAPI (blue), and actin with Alexa Fluor 488 phalloidin (green). A magnification (top) and a 3D surface rendered image (bottom) of the area indicated in
white are shown (E). Quantification of individual mitochondria (F), mean mitochondrial branch length (G), and mitochondrial area per cell (H) obtained using MiNa
Macro and Fiji software. In the violin plot, bars show themedian and dotted bars the quartiles (F–H). Data are representative of two independent experiments with
at least 50 cells analyzed per condition. *p < 0.05 by Student’s t test. n.s., not significant. Scale bars, 1 mm and 5 mm.
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tecture (Umesaki et al., 1995), as well as induction of immuno-
globulin A (IgA) and post-natal maturation of gut immune
functions, but are apathogenic (Gaboriau-Routhiau et al.,
2009; Klaasen et al., 1993; Schnupf et al., 2013; Schnupf
et al., 2017). Thus, the response to SFB that leads to the devel-
opment of Th17 cells proceeds without epithelial cell damage
and inflammatory infiltration of the lamina propria (Caballero
and Pamer, 2015). Using our IL-17A fate reporter mice(Hirota et al., 2011), we noticed that after the extensive re-deri-
vation program of mice prior to the start of the Francis Crick
Institute, we had lost SFB and could not detect Th17 cells in
the small intestine of our reporter mice. Upon introduction of
fecal material from germ-free mice monocolonized with SFB
(provided by Cerf-Bensussan), Th17 cells re-colonized the in-
testine of mice, reaching their maximal induction 2 weeks later.
We therefore took advantage of this situation to follow and
characterize the development of intestinal Th17 cells inducedImmunity 51, 1–13, July 16, 2019 9
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adheres to epithelium, but unlike SFB causes epithelial cell
death through effectors injected via a type III secretion system
(Crepin et al., 2016), resulting in the induction of an inflamma-
tory Th17 cells response (Torchinsky et al., 2009). Inflammatory
Th17 cells are highly plastic and tend to expand their cytokine
repertoire to include IFN-g, even losing expression of IL-17A
as we could determine with our fate reporter system.
Our data show that SFB-induced Th17 cells do not have
extensive plasticity and rarely switch on IFN-g in contrast
to Th17 cells that were induced after infection with
C. rodentium. In fact, a previous study found that resident intes-
tinal Th17 cells transdifferentiate into a regulatory phenotype
under inflammatory conditions rather than contribute to inflam-
mation (Gagliani et al., 2015). Under steady-state conditions,
however, we did not observe any acquisition of regulatory
T cell markers.
A potential caveat for our studies was the tissue-specific local-
ization of these two bacteria, with SFB resident in the small intes-
tine, whereas C. rodentium colonizes the colon. Nevertheless,
SFB-elicited Th17 cells are also found in the colon, albeit in
smaller numbers than in the small intestine, and Th17 cells
induced by C. rodentium infection can be found in the small in-
testine. In our RNA-seq comparison of Th17 cells induced by
these different bacteria, we therefore carefully compared both
colonic and small intestinal Th17 cells for both conditions.
Indeed, SFB-elicited Th17 cells in the colon were very similar
to those resident in the small intestine. Th17 cells elicited by
C. rodentium infection but resident in the small intestine had little
in common with the inflammatory Th17 cell population in the co-
lon and rather resembled the muted small intestinal population
that arises after SFB colonization, whereas the colonic Th17
population induced after infection was different from all other
conditions. Given that we also observed very low mRNA
expression of Il23a in the small intestine compared with that in
the colon, this might explain the reduced cytokine expression
of C.-rodentium-elicited Th17 cells, whose maintenance is
dependent on this cytokine.
We therefore focused our analysis on comparing colon-resi-
dent Th17 cells either elicited by SFB or by C. rodentium.
A series of studies have implicated SFB and the associated
Th17 cell response in systemic inflammatory conditions such
as EAE or arthritis (Lee et al., 2011; Wu et al., 2010). A caveat
for these studies is that they used germ-free mice, which are
generally deficient in mounting effective immune responses as
baseline. Our comparison of mice with diverse microbiota and
that contained SFB or no SFB did not indicate any difference
in the development of EAE whether or not SFB and intestinal
Th17 cells were present. This is in line not only with the speci-
ficity of intestinal Th17 cells for SFB (Yang et al., 2014),
but also with the fact that induction of EAE is dependent on
de-novo-induced Th17 cells in regional lymph nodes after the
immunization protocol. Likewise, our data, using inhibition of
egress from draining lymph nodes via administration of
FTY720, support the assumption that inflammatory Th17 cells
induced by infection withC. rodentium arose de novo from naive
CD4 T cells that then migrated to the colon from local lymph no-
des rather than from the expansion of pre-existing resident
SFB-elicited Th17 cells.10 Immunity 51, 1–13, July 16, 2019Although it would be difficult to distinguish resident barrier
protective Th17 cells from infection-induced Th17 cells in stan-
dard wild-type mice that are bred in SFB-containing conditions,
there are distinctions between the two states of Th17 cells that
might inform therapeutic targeting of inflammatory Th17 cells.
For instance, our group and others reported that intestinal
Th17 cells, unlike inflammatory Th17 cells, are not dependent
on IL-23 (Cua et al., 2003; Hirota et al., 2013) so that therapies
targeting IL-23 would not endanger indigenous small intestinal
Th17 cells. Consistently, mutations in the IL-23 receptor are
associated with increased IBD risk and increased protein
amounts of IL-23 are observed in subjects with IBD (Jostins
et al., 2012; Knights et al., 2013).
Our RNA-seq analysis highlighted profound differences in
metabolic conditions for tissue-resident versus inflammatory
Th17 cells, showing that tissue-resident homeostatic Th17 cells
mainly use OXPHOS, similarly to quiescent or memory T cells.
Thismetabolic state was also reflected in themorphology of their
mitochondria that resembled those previously reported in resting
memory T cells. Previous data suggested that Th17 cells, like
other T cell effector subsets and unlike regulatory T cells,
are highly glycolytic. However, these data were generated
exclusively from in-vitro-differentiated Th17 cells (Michalek
et al., 2011).
It is likely that, in order to support rapid proliferation and
effector functions, infection-induced Th17 cells predominantly
use glycolysis, as shown in the RNA-seq and metabolic flux
analyses. Therefore, targeting highly glycolytic Th17 cells is likely
to spare small intestinal Th17 cells.
A number of studies have focused on defining characteristics
of ‘‘pathogenic’’ Th17 cells, which were either derived from
in vitro differentiation cultures or isolated from the CNS of mice
with EAE (Gaublomme et al., 2015; Lee et al., 2012; Wang
et al., 2015). Our analysis of intestinal Th17 cells did not corrob-
orate previously identified markers thought to restrain (CD5L,
also known as AIM) or promote (Gpr65, Plzp, and Toso) Th17
cell pathology. Thismight be due to the fact that in-vitro-differen-
tiated Th17 cells do not adequately reflect the transcriptomic
state of resident intestinal Th17 cells and, on the other hand,
that Th17 cells involved in CNS inflammation are dissimilar to
Th17 cells induced by an intestinal infection. A comparison of
our dataset with previously published gene expression data
(Ghoreschi et al., 2010) indicated minor overlap, but suggested
that a small number of differentially expressed genes reported
in non-pathogenic Th17 cells generated in vitro were found in
those of tissue-resident Th17 cells, whilst some genes ex-
pressed in pathogenic Th17 cells were similarly expressed in
infection-induced Th17 cells in our dataset.
In conclusion, it appears that resident intestinal Th17 cells,
which in mice are almost exclusively induced by recognition of
SFB, remain in a non-inflammatory, barrier protective state,
display a muted metabolism and do not participate in systemic
inflammatory responses.
Even though a small proportion of SFB-specific Th17 cells can
be found in peripheral lymphoid organs, they display a resting
memory phenotype. Th17 cells induced by a pathogen such as
C. rodentium, however, generate a vigorous inflammatory
response, display substantial plasticity and primarily engage
aerobic glycolysis.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Il17aCreR26ReYFPmice (on a C57BL/6 background) were bred and maintained in individually ventilated cages at the Francis Crick
Institute, under specific pathogen-free conditions according to the protocols approved by the UK Home Office and the ethics com-
mittee (AWERP) of the Francis Crick Institute. Sex-matched male and female littermates were randomly assigned to experimental
groups in an age range of 4–10 weeks unless otherwise specified.
METHOD DETAILS
Colonization with Segmented Filamentous Bacteria
Mice in our colony were maintained SFB unless mentioned otherwise. To colonize mice with SFB, SFB mice were orally gavaged
at weaning with SFB-containing feces collected from SFB+ mice housed in our colony. Littermate controls were gavaged with SFB
feces. SFB colonization status was routinely examined before and after SFB gavage by quantitative PCR.
Quantitative PCR for Segmented Filamentous Bacteria
Flash-frozen stools were transferred in a Precellys’s soil grinding tube (Stretton Scientific) with 500 ml of Tris-EDTA buffer contain-
ing 200 mM Tris (pH 8.0), 20 mM EDTA, 200 mM NaCl; 210 ml of sodium dodecyl sulfate (SDS 20%) and 500 ml of
phenol:chloroform:isoamyl alcohol (25:24:1) (all from Ambion, Life technologies). Samples were homogenized with a Precellys
24 homogenizer (Bertin Technologies). The aqueous phase was removed after centrifugation and washed with isopropanol
and sodium acetate (pH 5.5) (all from ThermoFisher). Samples were incubated at 20C for 1 h, washed with 70% ethanol
(ThermoFisher), resuspended in TE buffer containing 10 mM Tris (pH 8.0) and 1 mM EDTA and incubated at 50C for 20 min.
DNA was further purified using QIAquick PCR Purification kit (Quiagen), quantified with Nanodrop Lite Spectrophotometer
(Thermofisher) and diluted to equal concentrations. Quantitative PCRwas performed with a QuantStudio Real-Time PCR (Thermo-
fisher) using QuantiFAST SYBR Green (Quiagen), 1 mg/ul BSA (New England BioLabs) and the following primers for Eubacteria
(UniF340 and UniR514) and SFB (SFB736F and SFB844R):e3 Immunity 51, 1–13.e1–e6, July 16, 2019
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Cells, Immunity (2019), https://doi.org/10.1016/j.immuni.2019.05.004UniF340: (50ACTCCTACGGGAGGCAGCAGT-30)
UniR514: (50ATTACCGCGGCTGCTGGC-30)
SFB736F: (50-GACGCTGAGGCATGAGAGCAT-30)
SFB844R: (50GACGGCACGGATTGTTATTCA-30)
For Eubacterial primers, initial 95C for 5 min, followed by 45 cycles of 95C for 10 seconds and 63C for 45 seconds. For SFB
primers initial 95C for 5 min, followed by 45 cycles of 95C for 10 seconds and 58C for 45 seconds. SFB abundance was calculated
by the threshold cycle (DCt) method and normalized to Eubacteria.
Quantitative PCR for intestinal tissue
RNAwas isolated from colon or small intestine using the RiboPure RNA purification kit, according to the manufacturer’s instructions.
One microgram total RNA was reverse-transcribed using the ThermoScript RT-PCR System kit (Applied biosystem) accordingly to
manufacturer’s instructions. The cDNA served as a template for the amplification of genes of interest and the housekeeping gene
(beta-2-microglobulin, b2m) by real-time quantitative PCR, using TaqMan Gene Expression Assays (Applied Biosystems), universal
PCR Master Mix (Applied Biosystems) and the ABI-PRISM 7900 sequence detection system (Applied Biosystems). mRNA expres-
sion was determined using the DCt method, relatively to B2m gene expression.
Infection with Citrobacter rodentium
For C. rodentium infection, a single colony of strain DBS100 (ATCC 51459; American Type Culture Collection) was transferred to
Luria-Bertani (LB) broth and grown to log phase, followed by centrifugation and resuspension in PBS. Mice were orally gavaged
with 200 ml of PBS containing 23 109C. rodentiumCFU. To determine bacterial load, tissue pieces were weighed and homogenized
in sterile PBS and serial dilutions were plated onto Brilliance E. coli/coliform Selective Agar (Fisher Scientific) or LB agar plates (liver)
for measurement of colony-forming units (CFU). For the administration of FTY720, six days prior the infection with C. rodentium or
PBS gavage, mice were intra-peritoneally injected with 3mg/kg FTY720 (Cayman Chemical) resuspended in PBS + 5% DMSO or
control vehicle, every day for six days. After C. rodentium infection or PBS gavage, the administration of the drug continued every
other day until the end of the experiment.
Cell isolation
Colon and small intestine were cut open longitudinally and incubated in wash buffer (IMDM 1%FCS, 5 mM EDTA, 10 mM HEPES,
penicillin/streptomycin, and 2 mM DTT) for 20 min at 37C with 200 r.p.m. shaking. Colon tissue was collected, cut into small pieces
and incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin, 50 mg/ml DNase I
(Roche)) containing 0.4cmg/ml Liberase TL (Roche) for 30 cmin at 37cC with 200 r.p.m. shaking. Small intestinal tissue was
collected, cut into small pieces and incubated in digestion buffer (IMDMsupplementedwith 1%FCS, 10mMHEPES, penicillin/strep-
tomycin, 50 mg/ml DNase I (Roche)) containing 1mg/ml collagenase VIII (Sigma) for 10min at 37Cwith 200 r.p.m. shaking. Single-cell
suspensions from colon and small intestine were further subjected to 40% Percoll (Amersham) density gradient centrifugation to
remove debris. Spinal cord from mice with a clinical score of 3 after immunization with MOG-CFA was mashed through 70-mm
mesh filter and subjected to 40% Percoll density gradient centrifugation. Spleen was mashed through 70-mm mesh filter and red
blood cells lysed with ACK lysing buffer, containing 0.15 M NH4Cl, 1 mM KHCO3 and 0.1 mM Na2EDTA with adjusted pH 7.2–7.4.
Flow cytometry and cell sorting
Single cell suspensions were prepared as described from the indicated organ and incubated with anti-CD16/32 (eBioscience) and
fixable live/dead cell dye (ThermoFisher). Cell suspensions for Th17 staining were incubated with antibodies against CD45 (BD Bio-
sciences), CD4 and TCR-b (Biolegend) whereas cell suspensions for ILC3 staining were incubated with antibodies against CD11b,
CD3, TCRgd, Gr1, CD19, TCR-b (all BioLegend) and Thy1.2, CD45 (all BD Biosciences). For intracellular staining, single-cell sus-
pensions were re-stimulated for 2 h in the presence of 1 ng/ml phorbol-12-myristate-13-acetate (PMA), 1mg/ml ionomycin and
10 mg/ml Brefeldin A (all Sigma), washed and stained for surface markers as described above. Cells were then fixed in eBioscence
Fix/Perm buffer or 3.7% formaldehyde (for preservation of eYFP fluorescence) for 30 or 10 min on ice, respectively, followed by
permeabilization in eBioscience permeabilization buffer for 30 min in the presence of antibodies against IL-22 (eBioscience),
IFN-g and IL17-A (BioLegend) for Th17 or RORgt (BD Bioscences) for ILC3. Samples were FSC-A/SSC-A gated to exclude debris,
SSC-W/SSC-A and FSC-W/FSC-A gated to select single cells and gated to exclude live/dead-dye+ dead cells. Th17 cells were
gated as CD45+CD4+TCR-b+eYFP+. ILC3 cells were gated as CD45+CD11bCD3TCRgdGr1CD19TCR-bThy1.2+RORgt+.
Samples were run on a BD Fortessa X20 and analysis was performed with FlowJo v10 (Tree Star) software. For Th17 cell sorting,
single-cell suspensions from the spleen were enriched for CD4 T cells with EasySep Mouse CD4+ T Cell Isolation kit according to
manufacturer’s instructions, whereas suspensions from the intestine were FACS-sorted without any prior enrichment. Cell suspen-
sions were stained with propidium iodide (Sigma) to exclude dead cells and with antibodies against CD45, CD4, and TCR-b (all from
Biolegend) and Th17 cells sorted as live CD45+CD4+TCR-b+eYFP+ cells. For dendritic cell sorting, spleens from RAG-1/ mice
were incubated in digestion buffer (IMDM supplemented with 1% FCS, 10 mM HEPES, penicillin/streptomycin) containing
1 mg/mL Collagenase D and 20 mg/mL DNase I (all from Roche) for 1 h at 37C. Cell suspensions were then mashed
through 70-mm mesh filter, lysed for red blood cells and stained with propidium iodide and antibodies against CD45, CD11c,Immunity 51, 1–13.e1–e6, July 16, 2019 e4
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formed using a MoFlo XDP (Beckman Coulter).
Th17 cell culture
Th17 cells were sorted as described and plated at 104 cells per well. At 24 h cytokines were measured in the supernatant by
MILLIPLEX MAP mouse Th17 Magnetic Bead Panel kit (Merck). For co-culture experiments Th17 cells were plated at 104 cells
per well with dendritic cells at 3:1 ratio, together with 2.5 mM SFB peptide or 1 mg/mL EspA.
Recombinant proteins
SFB peptide derived from SFBNYU_003340 (LVFDVQFSGAVPNKT) (Yang et al., 2014) was generated by the Crick Peptide
Chemistry platform. EspA was purified from His-EspA-expressing E. coli (Knutton et al., 1998), kindly provided by Dougan Gordon
(Sanger Institute), using Ni-NTA Spin kit (Qiagen) according to manufacturer’s instructions.
EAE induction
Mice were injected subcutaneously at two sites with 100ml of an emulsion containing 250 mg MOG peptide (amino acids 35–55) and
250 mg killed Mycobacterium tuberculosis (strain H37Ra) from Hooke Labs (Hooke Laboratories). Mice received 200 ng Bordetella
pertussis (Calbiochem) intraperitoneally on the day of immunization and 2 d later. Clinical assessment of EAE was done daily and
clinical scores were assigned according to the following criteria: 0, unaffected; 1, flaccid tail; 2, impaired righting reflex and/or
gait; 3, partial hindlimb paralysis; 4, total hind limb paralysis. All mice with a clinical score of 4 were killed.
Colon explant cultures
Intestinal tissue pieces (0.5–1 cm length) were cultured for 24ch in complete IMDMmedium. Cytokines were measured in the super-
natant by MILLIPLEXMAP mouse Th17 Magnetic Bead Panel kit (Merck) and concentrations were normalized to the weight of the
explants.
RNA-sequencing
Single cell suspensions from small intestine and colon were generated, stained and sorted as described above to purify Th17 cells.
Each replicate was pooled from three to six mice and three biological replicates were collected for each group, with the exception of
C. rodentium-induced colonic Th17 cells, with five biological replicates. RNAwas isolatedwithmiRNeasyMicro kit (Quiagen) accord-
ing to the manufacturer’s protocol. Amplified cDNA was prepared using the SMART-Seq V4 ultra low input RNA kit (Takara), accord-
ing to the manufacturer’s instructions. Sequencing libraries were generated using the Ovation Ultralow V2 kit (NuGEN) according to
manufacturer’s instruction. Libraries were assessed using the TapeStation 2200 (Agilent Technologies) and sequenced by paired-
end 100 base pair reads using the Illumina HiSeq platform. Reads were aligned to the GRCm38 Ensembl Release 86 mouse genome
using Bowtie2 (Langmead and Salzberg, 2012) and quantified using RSEM (Li and Dewey, 2011). Differential genes were found using
DESeq2 (Love et al., 2014) (version 1.16.1) in R (R Development Core Team, 2015) (version 3.4.1), using a two-factor model with in-
teractions to account for difference between tissues, differences between treatments, and tissue-specific treatment effect. We used
a false discovery threshold of 0.05 on the resulting Wald statistic. All four experimental conditions were used to estimate per-gene
dispersion values. For the heat map of condition similarity (Figure 5A), each experimental group was summarized as the sum across
replicates of the raw counts. The Poisson distance (Witten, 2012) between pairs of experimental groups was taken to assess how
similar the conditions are using complete hierarchical clustering. For the scatter plot of differentially expressed genes (Figure 5C),
low normalized read count (average across conditions less than 4) were removed to ensure the trend was not driven by noise: omit-
ting this filtering showed no qualitative difference. For the scatter plot in Fig.S5D we compared our differentially expressed gene list
generated from colonic SFB- versus C. rodentium-elicited Th17 cells to a publicly available expression dataset (GSE23505). Firstly,
we identified the list of differentially expressed genes using the Limma package in R and selected genes that were statistically sig-
nificant (p value < 0.001) in the published dataset. We then compared the generated gene list to the differentially expressed genes in
our dataset (adjusted p value < 0.05). For canonical pathway analysis (Fig.5D), differentially expressed genes between SFB- and
C.-rodentium-elicited colonic Th17 cells with adjusted p value < 0.05 and fold change > 1.5 were input in Ingenuity Pathway Analysis
(IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity). Enriched KEGG metabolic pathways (Fig.6A) and reporter metabolites
(Fig.6B) (Patil and Nielsen, 2005) were identified from differentially expressed genes in SFB- versus C. rodentium-elicited colonic
Th17 cells (adjusted p value < 0.05). Specifically, we usedDAVID analysis (Huang da et al., 2009) to identify KEGG enriched pathways
from up-regulated genes and PIANO R package (V€aremo et al., 2013) to identify reporter metabolites from differentially expressed
genes. Enzymes, metabolites and their topological relations used for the metabolic analysis were obtained from a mouse
genome-scale metabolic model (Mardinoglu et al., 2015). In KEGG metabolic pathway analysis, we excluded metabolic pathways
not originated from the host, such as biosynthesis of antibiotics, drug metabolism by cytochrome P450 and metabolism of
xenobiotics by cytochrome P450. Consistently, in the reporter metabolite analysis, we excluded metabolites originating from these
pathways, together with artificial reactions inferred on the genome-scale metabolic model and focused on up-regulatedmetabolites.
A selection of reporter metabolites is displayed in Fig.6B, the complete list of results can be found in Table S1.e5 Immunity 51, 1–13.e1–e6, July 16, 2019
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After FACS-sorting, Th17 cells (7 3 104 per well) were seeded onto standard Seahorse 8-well plates coated with Poly-D-Lysine
(50 mg/mL, Sigma) and assayed on a Seahorse XFp Analyzer (Agilent Technologies, Santa Clara, USA). The plates were centrifuged
at 300g for 5 min and kept at 37C for 30–60 min. Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) were
measured in XFmedia with pH adjusted to 7.4. To investigate mitochondrial respiration and energetic phenotypes Seahorse XFp Cell
Mito Stress Test kit (Agilent Technologies) was used. The injection strategy was as follow, first: oligomycin (1 mM at final concentra-
tion), second: carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) (1 mM at final concentration), and third: rotenone and
antimycin A (0.5 mM at final concentration). The WAVE software (version 2.6) was applied for further data analysis.
Confocal microscopy
After FACS-sorting, Th17 cells were cultured in m-Slide 8 well glass bottom slides (ibidi GmbH) and incubated for 30 min at 37Cwith
MitoTracker Red CMXRos (100 nM, ThermoFisher). After two rinses with PBS, cells were fixed with paraformaldehyde 3.7% for
15 min. DAPI (1 mg/mL, Sigma) and Alexa Fluor 488 Phalloidin (150 nM, ThermoFisher) were used for nuclear and actin staining,
respectively.
Z-stack images were acquired using a Leica TCS SP8 (Leica Microsystems, Germany) confocal microscope and spatial deconvo-
lution and 3D surface-rendered images were carried out with Huygens Software (SVI, The Netherlands). Mitochondrial morphology
was analysed using the macro MiNa in Fiji software (Schindelin et al., 2012; Valente et al., 2017).
QUANTIFICATION AND STATISTICAL ANALYSIS
Details of the statistical tests applied to replicates of datasets shown in Figures can be found in the corresponding Figure legends. All
data points and ‘‘n’’ values reflect biological replicates (e.g., mice), except in Figures 2E, 3B, and 3C where they represent technical
replicates. Statistical analyses were performed using GraphPad Prism 10 software.
DATA AND CODE AVAILABILITY
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Figure S1. Th17 cell induction by SFB in the colon and C. rodentium in the small intes-
tine, related to Figure 1. 
Absolute numbers of Th17 cells in the colon of mice colonised with SFB (A) and the small 
intestine of mice infected with C. rodentium (B) at 0 (n=6), 1 (n=10-6), 2 (n=12-6) and 4 
(n=12-10) weeks post-gavage. In the graphs, bars show the mean and each symbol repre-
sent an individual mouse from two pooled independent experiments. **p < 0.01, ****p < 
0.0001 by one-way ANOVA with Dunnett’s post-test.
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AFigure S2. Cytokine production by SFB-elicited Th17 cells in the colon, related to Figure 2. 
Quantification of intracellular staining for IL-17A and IL-22 or IFN-γ in Th17 cells from the colon of 
mice colonised with SFB (A) and the small intestine of mice infected with C. rodentium (B) at 1 (n=4 
and 6), 2 (n=6) and 4 (n=4 and 10) weeks post-gavage. Lamina propria cells were isolated at the 
indicated time-point, re-stimulated with PMA and Ionomycin and Brefeldin A for 2 hours and ana-
lysed by FACS. Bars show the mean ± s.e.m. for the indicated populations and each symbol repre-
sents an individual mouse from two pooled independent experiments. (C) Fold change induction of 
listed genes quantified by qPCR in the SI and colon of mice colonised with SFB (n=3 and n=4) or 
infected with C. rodentium (n=5), 1 week post-gavage. Fold change is calculated on the matching 
uncolonised organ (uncol.) (n=6) and gene expression normalised against ß-2-microglobulin. Bars 
show the mean + s.e.m. from two pooled independent experiments. *p < 0.05, **p < 0.01, ****p < 
0.0001 by one-way ANOVA with Dunnett’s post-test.
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Figure S3. SFB does not impact the course of EAE, related to Figure 3. 
(A) Relative abundance of Segmented Filamentous bacteria (SFB) in the faeces of mice reconstituted 
with SFB- (n=4) or SFB+ (n=6) faeces at 12 days upon EAE immunisation. SFB genomic 16s was 
quantified in the faeces by qPCR analysis. Abundance of SFB was normalised to Eubacteria. (B) 
Absolute numbers of Th17 cells in the small intestine (B) or spinal cord (D) of SFB- and SFB+ mice 
(n=4) at 12 days upon EAE immunisation. (C) Clinical scores of SFB- (n=10) and SFB+ mice (n=10) 
mice upon EAE immunisation.  Results are pooled from two independent experiments. Data are 
shown as mean + s.e.m. **p < 0.01 by Student t-test. n.s., not significant; n.d., not detected.
AFigure S4. FTY720 treatment does not affect numbers of SFB-elicited Th17 cells and C. 
rodentium-elicited ILC3 cells, related to Figure 4. 
Mice were orally gavaged with SFB+ faeces 4 weeks prior the gavage with PBS (A, B, C) or C.ro-
dentium (D) (at day 0). Six days prior the PBS or C.rodentium gavage, mice were intra-peritoneally 
injected with FTY720 (3mg/kg) or control vehicle every day. FTY720 and control vehicle administra-
tion continued after the PBS or C. rodentium gavage every other day until the end of the experi-
ment. (A) Absolute numbers of colonic Th17 cells (n=4 and n=5). Quantification of intracellular 
staining in colonic Th17 cells (n=4 and n=5) for IL-17A and IL-22 (B) or IFN-γ (C). (D) Absolute 
numbers of colonic ILC3 cells (n=6 and n=8). Bars show mean ± s.e.m. and each symbol represent 
an individual mouse. Results are representative of two independent experiments. n.s., not signifi-
cant by Student t-test.
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Figure S5. Gene expression of pathways activated in SFB-induced colonic Th17 cells and 
shared gene expression with in vitro generated Th17 cells, related to Figure 5. 
Expression (log2-fold change) of genes identified by ingenuity pathway analysis (IPA) in sumoyl-
ation (A), PTEN (B) and sirtuin (C) pathways in colonic SFB- vs. C.rodentium-induced Th17 
cells. (D) Scatter plot of genes identified from in vitro generated non-pathogenic vs. pathogenic 
Th17 cells (Ghoreschi et al, 2010) (p < 0.001) detected in SFB or C. rodentium colon Th17 cells. 
Genes in blue (listed in E) and in red (listed in F) are significantly different in SFB vs. C. roden-
tium colon Th17 cells (adj p < 0.05) and follow the same direction of the published dataset. 
Values in E and F are log2 fold change of genes in the indicated comparison. 
